Olugbenga-Bello Adenike Iyanuoluwa, Bamidele Olayinka Oluwabusola, Ilori Oluwatosin Ruth, Ige Roseline Olabisi, Anegbe Norbertta Ekpen
Department of Community Medicine, Faculty of Clinical Sciences, College of Health Sciences, Ladoke Akintola University of Technology, Ogbomoso, Oyo State.
Department of Community Medicine, UNIOSUN Teaching Hospital, Osogbo, Osun State.
J Public Health Afr. 2023 May 29;14(7):2393. doi: 10.4081/jphia.2023.2393. eCollection 2023 Jul 26.
The development of COVID-19 vaccines holds great potential for controlling the spread of SARS-CoV-2. Vaccines, irrespective of the disease are generally fraught with hesitancy, and Nigeria has a history of vaccine hesitancy.
This study aimed at determining the perception of community members about the COVID-19 vaccine and their readiness to accept the vaccine in South West, Nigeria.
A descriptive cross-sectional study design was employed to collect data from consenting adults using a structured online questionnaire for a period of three weeks. Data were subjected to a Chi-square test and logistic regression for bivariate and multivariate analysis, respectively.
A total of 807 respondents participated in the survey with 57.7% males and 42.3% females. Forty-five respondents (5.6%) had previously been diagnosed with COVID-19 while 11.5% of the respondents had co-morbidity. The overall perception of COVID-19 vaccines was good. Fifty-nine (59%) percent of the respondents were willing to accept the vaccine and will also encourage their family members to take the vaccine. Vaccine origin and cost were determinants of vaccine acceptability. Nonacceptability of the vaccine (61.6%) was based on possible adverse effects of the vaccine and mistrust of the government. Educational level, skill status, type of employment, and sector of employment were associated (P<0.001) with the acceptability of the COVID-19 vaccine.
Citizens were willing to take COVID-19 vaccines, however, a lack of trust in government programs might undermine the vaccine campaign. Hence, the government needs to rebuild trust with the citizens towards achieving a high vaccination rate for COVID-19.
新冠病毒疫苗的研发对于控制严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的传播具有巨大潜力。无论针对何种疾病，疫苗普遍存在犹豫现象，而尼日利亚向来有疫苗犹豫的历史。
本研究旨在确定尼日利亚西南部社区成员对新冠病毒疫苗的认知以及他们接受该疫苗的意愿。
采用描述性横断面研究设计，通过结构化在线问卷，在三周时间内从同意参与的成年人中收集数据。分别对数据进行卡方检验和逻辑回归分析，以进行双变量和多变量分析。
共有807名受访者参与了调查，其中男性占57.7%，女性占42.3%。45名受访者（5.6%）此前被诊断感染过新冠病毒，11.5%的受访者患有合并症。对新冠病毒疫苗的总体认知良好。59%的受访者愿意接种疫苗，并且还会鼓励其家人接种。疫苗的产地和成本是疫苗可接受性的决定因素。不接受疫苗（61.6%）的原因是担心疫苗可能产生的不良反应以及对政府的不信任。教育程度、技能状况、就业类型和就业部门与新冠病毒疫苗的可接受性相关（P<0.001）。
公民愿意接种新冠病毒疫苗，然而，对政府项目缺乏信任可能会破坏疫苗接种运动。因此，政府需要重建与公民之间的信任，以实现新冠病毒的高接种率。
